24 May 2013
Keywords: shire, elaprase, cleared, mexico, uk, drugmaker, idursulfase
Article | 18 February 2008
UK drugmaker Shire's Elaprase (idursulfase), a human enzyme replacement therapy for Hunter syndrome, has been approved for commercial sale by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.